The pan-PPAR agonist #lanifibranor improves cardiometabolic health in patients with #MASLD .
nature.com/articles/s4146…

Cardiovascular disease is the leading cause of mortality in #MASLD and type 2 diabetes. diabetesresearchclinicalpractice.com/article/S0168-…

Nomenclature change:
NAFLD is out. MASLD is in.

#pcp2024

MASLD=NAFLD
Largest and first data from Asia suggesting -
- 98% of NAFLD patients meet MASLD criteria.
- Can use old NAFLD data under new MASLD definition.
- Diagnostic and therapeutic studies need not be repeated.
AASLD
EASLnews Maru Rinella MD Aleksander Krag Jeffrey V. Lazarus

REVIEW | Lifestyle interventions in #NAFLD / #MASLD

nature.com/articles/s4157…

🚨🚨 New viewpoint in Liver International The #MASLD - #MAFLD debate: Another phase of eminence versus evidence!
➡️ The authors: “With the growing pressure to abruptly, adopt the newly proposed MASLD definition without thoughtful consideration, this is a remainder of our initial call of

Liver stiffness has insufficient specificity and PPV for diagnosis of advanced fibrosis in #MASLD with BMI ≥ 35. A sequential strategy of noninvasive tests maximizes PPV while reducing the proportion of patients in the indeterminate zone.
onlinelibrary.wiley.com/doi/full/10.10…

Our #LiverBrainAxis group will be represented by Matt Siddle at #EASLcongress 2024 who's presenting a poster on the Liver-Brain Axis in MASLD

Dr Anna Hadjihambi EASLnews EASL Education School of Immunology & Microbial Sciences NeuroImmunePhD #LiverTwitter #Hepatology

Fatty Liver Disease or MASLD are an Epidemic. Does MASLD always track with BMI? No!
We introduce the concept of disproportionate liver fat (DLF). Liver fat in excess of BMI
doi.org/10.1016/j.ahj.…

Alain Bertoni Erin D. Michos, M.D. @Ambarishpandey Sanjiv J. Shah, MD Ravi Patel Jon Kusner

#DDW2024 💡 Join us in room 202B to hear about #multidisciplinary management of #MASLD #obesity Sonal Kumar, MD MPH with an excellent talk on new #GLP -1 #ozempic in MASLD. I am next: #Endobariatrics !

Saddened to hear about the untimely passing of Stephen Harrison, a giant who has moved the #MASLD field in leaps, not steps, towards better understanding and treatment. His legacy remains with us for many many years. RIP.

DE ENFERMEDAD DE HÍGADO GRASO NO ALCOHÓLICO (NAFLD) A DISFUNCIÓN METABÓLICA ASOCIADA A ENFERMEDAD ESTEATÓTICA HEPÁTICA (MASLD)

Han sido años de cambios conceptuales y de nomenclatura.

Abro hilo.

Prof. Vincent Wong A giant in hepatology and well known scientist who has been relentlessly working on MASLD/NAFLD will educate us about the only FDA approved drug “Resmetirom”
CUHK Medicine Ajay Duseja Shivaram P Singh Daniel Huang Cheng Han Ng Rohit Loomba #livertwitter

The liver community mourns the loss of Dr. Stephen Harrison, a friend and a visionary in MASLD clinics and clinical research, whose contributions have shaped the current state of the field.

We extend our deepest condolences to Dr. Harrison’s family and colleagues during this

🌟 Don't miss the exclusive interview with Prof. Vincent Wong!
Discover insights into his research on viral #hepatitis and #MASLD , plus his role in shaping global management guidelines for liver diseases. !
🌟Watch the interview vedio: oaepublish.com/interviews/mto…
#Livertwitter

**Happening Now**

Today's session, 'MASLD for the Non-Hepatologist,' hosted by AASLD's FOLD Committee, is overflowing. #DDW2024 #BeInTheKnow

The grade of obesity affects the noninvasive diagnosis of advanced fibrosis in individuals with MASLD

The grade of obesity affects the detection of MASLD-related AF. A sequential use of LSM/A3+could improve AF detection in patients with BMI ≥ 35.

onlinelibrary.wiley.com/doi/full/10.10…

MASH Day 2024! Thank you to the Madrigal team for visiting UCSD!

OBESIDAD Y ENFERMEDAD ESTEATÓTICA HEPÁTICA ASOCIDADA A DISFUNCIÓN METABÓLICA (MASLD)

¿Es la pérdida de peso la (única) clave para tratar MASLD?

drive.google.com/file/d/18lF7eF…